Mirae Asset Global ETFs Holdings’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$369K Buy
3,830
+69
+2% +$6.9K ﹤0.01% 2045
2025
Q4
$366K Buy
3,761
+36
+1% +$3.09K ﹤0.01% 2045
2025
Q3
$265K Sell
3,725
-734
-16% -$48.9K ﹤0.01% 2173
2025
Q2
$267K Sell
4,459
-352
-7% -$19.3K ﹤0.01% 2132
2025
Q1
$252K Buy
4,811
+234
+5% +$13.1K ﹤0.01% 2197
2024
Q4
$252K Buy
4,577
+204
+5% +$10.7K ﹤0.01% 2263
2024
Q3
$220K Buy
4,373
+1,119
+34% +$51.6K ﹤0.01% 2331
2024
Q2
$143K Buy
+3,254
New +$138K ﹤0.01% 2421

Other funds holding IRMD

Mirae Asset Global ETFs Holdings's IRMD Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its iRadimed (IRMD) stake by 1.8% in Q1 2026, buying an estimated $6.9K and bringing the position to 3,830 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #2045.

Mirae Asset Global ETFs Holdings first reported a position in IRMD in Q2 2024 and has held it in 8 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 3,830 shares of iRadimed worth $369K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 69 iRadimed shares in Q1 2026, an estimated $6.9K.
  • iRadimed made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2045 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in iRadimed in Q2 2024 and has held it in 8 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.